Human T-cell lymphotropic viruses type 1 and 2 (HTLV-I/-II)

Infusionstherapie und Transfusionsmedizin

Volumn 26, Issue 6, 1999, Pages 321-326

  Seitz, Rainer ^a  

^a PAUL EHRLICH INSTITUT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY DETECTION; BLOOD TRANSFUSION; BOVINE LEUKEMIA VIRUS; DISEASE ASSOCIATION; GENE SEQUENCE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; IMMUNOASSAY; NONHUMAN; PREVALENCE; RETROVIRUS; REVIEW; VIRUS INFECTION;

BOVINAE; BOVINE LEUKEMIA VIRUS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 2; UNIDENTIFIED RETROVIRUS;

EID: 0032739372     PISSN: 10198466     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. Murphy FA, Fauquet CM, Bishop DHL, Ghabrial SA, Jarvis AW, Martelli GP., Mayo MA, Summers, MD: Virus Taxonomy: Classification and Nomenclature of Viruses. Wien, Springer, 1995.
2. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC: Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 1980;77:7415-7419.
3. Miyoshi I, Kubonishi L, Yoshimoto S, Akagi T, Otsuki Y, Shiraishi Y, Nagata K, Hinuma Y: Type C virus particles in a cord T-cell line derived by cocultivating normal human cord leukocytes and human leukemic T-cells. Nature 1981;294:770-771.
4. Gessain A, Barin F, Vernant JC, Gout O, Maurs L, Calendar A, de Thé G: Antibodies to human T-lymphotropic virus type-1 in patients with tropical spastic paraparesis. Lancet 1985;ii:407-409.
5. Osame M, Usuku K, Izumo S, Ijichi N, Amitani H, Igata A, Matsumoto M, Tara M: HTLV-1 associated myelopathy, a new clinical entity. Lancet 1986;i: 1031-1032.
6. Iwakura Y, Tosu M, Yoshida E, Takiguchi M, Sato K, Kitajima I, Nishioka K, Yamamoto K, Takeda T, Hanaka M, Yamamoto K, Sekiguchi T: Induction of inflammatory arthropathy resembling rheumatoid arthritis in mice transgenic for HTLV-1. Science 1991;253:1026-1028.
7. Murphy EL, Goedert JJ, Blattner WA, Gibbs WN, Campbell M: Modelling the risk of adult T-cell leukemia/lymphoma in persons infected with human T-lmphotropic virus type I. Int J Cancer 1989; 43:250-253.
8. Kalyanaraman VS, Sarngadharan MG, Robert-Guroff M, Miyoshi I, Blayncy D, Golde D, Gallo RC: A new subtype of human T-cell leukemia virus (HTLV-2) associated with a T-cell variant of hairy cell leukemia. Science 1982;218:571-573.
9. Murphy EL: HTLV-2 related disease. Lancet 1993; 341:888.
10. Hjelle B, Appenzeller O, Mills R, Alexander S, Torrez-Martinez N, Jahnke R, Ross G: Chronic neurodegenerative disease associated with HTLV-II infection. Lancet 1992;339:645.
11. Sugiyama H, Doi H, Yamaguchi K, Tsuji Y, Miyamoto T, Hino S: Significance of postnatal mother-to-child transmission of human T-lymphotropic virus type-I on the development of adult T-cell leukemia/lymphoma. J Med Virol 1986;20: 253-260.
12. Yamaguchi K: Human T-lymphotropic virus type I in Japan. Lancet 1994;343:213-216.
13. Yamamoto N, Okada M, Koyanagi Y: Transformation of human leukocytes by cocultivation with an adult T cell leukemia virus producer cell line. Science 1982;217:737-739.
14. Manns A, Wilks RJ, Murphy EL, Haynes G, Figuora JP, Barnett M, Hanchard B, Blattner WA: A prospective study of transmission by transfusion of HTLV-I and risk factors associated with seroconversion. Int J Cancer 1992;51:886-891.
15. Sullivan MT, Williams AE, Fang CT, Grandinetti T, Poiesz BJ, Ehrlich GD, and The American Red Cross HTLV-I/II Collaborative Group: Transmission of human T-lymphotropic virus type I and II by blood transfusion. A retrospective study of recipients of blood components (1983 through 1988). Arch Int Med 1991;151:2043-2048.
16. Manns A, Murphy EL, Wilks R, Haynes G, Figueroa JP, Hanchard B, Barnett M, Drummond J, Waters D, Cerney M, Seals JR, Alexander SS, Lee H, Blattner WA: Detection of early human T-cell lymphotropic virus type 1 antibody patterns during seroconversion among transfusion recipients. Blood 1991;77:896-905.
17. Levine PH, Jacobson S, Elliott R, Cavallero A, Colclough G, Dorry C, Stephenson C, Knigge RM, Drummond J, Nishimura M, Taylor ME, Wiktor S, Shaw GM: HTLV-II Infection in Florida Indians. AIDS Res Hum Retroviruses 1993;9:123-127.
18. Zanetti AR, Zehender G, Tanzi E, Galli C, Rezza G, Cargnel A, Boschini A, Mari D, Pizzocolo G, Mazzota F, Canavaggio M, Lee H: HTLV-II among Italian intravenous drug users and hemophiliacs. Eur J Epidemiol 1992;8:702-707.
19. Höllsberg P, Hafler DA: Pathogenesis of diseases induced by human lymphotropic virus type I infection. Seminars in medicine of the Beth Israel Hospital, Boston. N Engl J Med 1993;328:1173-1182.
20. Bastian I, Gardner J, Webb D, Gardner I: Isolation of a human T-lymphotropic virus type I strain from Australian Aboriginals. J Virol 1993;67:843-851.
21. Gessain A, Boeri E, Yanagihara R, Gallo R, Franchini G: Complete nucleotide sequence of a highly divergent human T-cell leukemia (lymphotropic) virus type I (HTLV-I) variant from Melanesia: Genetic and phylogenetic relationship to HTLV-I strains from other geographical regions. J Virol 1993;67:1015-1023.
22. Blattner WA, Kalyanaraman VS, Robert-Guroff M, Lister TA, Galton DA, Sarin PS, Crawford MH, Catovsky D, Greaves M, Gallo RC: The human type-C retrovirus, HTLV, in the blacks from the Caribbean region and relationship to adult T-cell leukemia/lymphoma. Int J Cancer 1982;30:257-264.
23. Kwok S, Gallo D, Hanson C, McKinney N, Poiesz B, Sninsky JJ: High prevalence of HTLV-II among intravenous drug abusers: PCR confirmation and typing. AIDS Res Hum Retroviruses 1990;6:561-565.
24. Maloney EM, Biggar RJ, Neel JV, Taylor ME, Hanh BH, Shaw GM, Blattner WA: Endemic human T cell lymphotropic virus type 2 infection among isolated Brazilian Amerindians. J Inf Dis 1992;166:100-107.
25. Coste J, Lemaire JM, Courouce AM: HTLV-I/II antibodies in French blood donors. Lancet 1990; 335:1167-1168.
26. Mowbray J, Mawson S, Chawira A, Skidmore S, Boxall E, Desselberger U, Nightingale S: Epidemiology of T-cell leukemia/lymphoma virus type 1 (HTLV-1) infections in a subpopulation of Afro-Caribbean origin in England. J Med Virol 1989;29: 289-295.
27. Hunsmann G, Schneider J, Bayer H, Berthold H, Schimpf K, Kabisch H, Ritter K, Bienzle H, Schmitz H, Kern P, Dietrich M: Antibodies to adult T-cell leukemia virus (ATLV/HTLV-I) in AIDS patients and people at risk of AIDS in Germany. Med Microbiol Immunol 1985;173:241-250.
28. Pauli G, Ehm I, Gelderblom HR, Koch MA: HTLV-1-Infektionen in der Bundesrepublik Deutschland. Bundesgesundheitsblatt 1990;33:205-209.
29. Detmar M, Pauli G, Anagnostopoulos I, Wunderlich U, Herbst H, Garbe C, Stein H, Orfanos CE: A case of classical mycosis fungoides associated with human T-cell lymphotropic virus type 1. Br J Dermatol 1991;124:198-202.
30. Rolfs A, Junghan U, Pauli G, Koenecke C, Grützedieck V: Neurologisches Krankheitsbild und Diagnostik einer HTLV-1 Infektion mit Paraparese, Myositis und Sjögren-Syndrom. 2. Deutscher AIDS-Kongress, Berlin, 23./24.1.1989, Abstract 312.
31. Kitze B, Turner RW, Burchhardt M, Poser S, Hunsmann G, Weber T: Differential diagnosis of HTLV-I-associated myelopathy and multiple sclerosis in Iranian patients. Clin Invest 1992;70:1013-1018.
32. Reinhardt P, Maschmeyer G, Carstanjen D, Schulze G, Herrmann F, Fleischer C, Ellerbrok H, Schlegelberger B, Pauli G, Ludwig WD: Erste nicht-importierte HTLV-I positive adulte T-Zell-Leukämie (ATL) in Deutschland. Jahrestag Gesellsch Virol, 6.-9.3.1996, Jena, Abstract 254.
33. HTLV European Research Network (HERN), Taylor GP, Weber JN, et al: Sero-epidemiology of the human T-cell leukaemia/lymphoma viruses in Europe. J Acquir Immune Defic Syndr Hum Retrovirol 1996;13:68-77.
34. Fleischer C, Kücherer C, Michel P, Wiese W, Stahl-Hennig C, Bodemer C, Hunsmann G, Pauli G: Detection of rarte cases of HTLV-I and -II infections and high numbers of HTLV-seroindeterminate results in Bavarian blood donors. Infusionsther Transfusionsmed 1999;26:328-334.
35. Hitzler W, Kiefhaber K, Runkel S, Jochum C: Prävalenz des humanen T-Zelleukämie-Virus I/II (HTLV-I/-II) bei Dauerblutspendern aus urbanen und ländlichen Gebieten. Infusionsther Transfusionsmed 1996;33:211-215.